PL3202814T3 - Poli(laktyd/glikolid) o niskim efekcie nagłego uwalniania i sposoby wytwarzania polimerów - Google Patents

Poli(laktyd/glikolid) o niskim efekcie nagłego uwalniania i sposoby wytwarzania polimerów

Info

Publication number
PL3202814T3
PL3202814T3 PL15185218T PL15185218T PL3202814T3 PL 3202814 T3 PL3202814 T3 PL 3202814T3 PL 15185218 T PL15185218 T PL 15185218T PL 15185218 T PL15185218 T PL 15185218T PL 3202814 T3 PL3202814 T3 PL 3202814T3
Authority
PL
Poland
Prior art keywords
glycolide
lactide
poly
methods
produce polymers
Prior art date
Application number
PL15185218T
Other languages
English (en)
Inventor
Eric Dadey
John Middleton
Richard L. Norton
Original Assignee
Tolmar Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tolmar Therapeutics, Inc. filed Critical Tolmar Therapeutics, Inc.
Publication of PL3202814T3 publication Critical patent/PL3202814T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88—Post-polymerisation treatment
    • C08G63/90—Purification; Drying
PL15185218T 2007-02-15 2008-02-13 Poli(laktyd/glikolid) o niskim efekcie nagłego uwalniania i sposoby wytwarzania polimerów PL3202814T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90143507P 2007-02-15 2007-02-15
EP08725511.3A EP2115029B1 (en) 2007-02-15 2008-02-13 Low burst poly-(lactide/glycolide) and methods to produce polymers
PCT/US2008/001887 WO2008100532A1 (en) 2007-02-15 2008-02-13 Low burst poly-(lactide/glycolide) and methods to produce polymers
EP15185218.3A EP3202814B1 (en) 2007-02-15 2008-02-13 Low burst poly-(lactide/glycolide) and methods to produce polymers

Publications (1)

Publication Number Publication Date
PL3202814T3 true PL3202814T3 (pl) 2020-01-31

Family

ID=39504385

Family Applications (3)

Application Number Title Priority Date Filing Date
PL19203071.6T PL3660073T3 (pl) 2007-02-15 2008-02-13 Poli(laktyd-ko-glikolid) o niskim nagłym uwalnianiu
PL08725511T PL2115029T3 (pl) 2007-02-15 2008-02-13 Poli(laktyd/glikolid) o niskim efekcie nagłego uwalniania i sposoby wytwarzania polimerów
PL15185218T PL3202814T3 (pl) 2007-02-15 2008-02-13 Poli(laktyd/glikolid) o niskim efekcie nagłego uwalniania i sposoby wytwarzania polimerów

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL19203071.6T PL3660073T3 (pl) 2007-02-15 2008-02-13 Poli(laktyd-ko-glikolid) o niskim nagłym uwalnianiu
PL08725511T PL2115029T3 (pl) 2007-02-15 2008-02-13 Poli(laktyd/glikolid) o niskim efekcie nagłego uwalniania i sposoby wytwarzania polimerów

Country Status (16)

Country Link
US (7) US9187593B2 (pl)
EP (3) EP3660073B1 (pl)
JP (3) JP5342459B2 (pl)
CA (1) CA2678350C (pl)
CY (2) CY1116785T1 (pl)
DK (3) DK3202814T3 (pl)
ES (3) ES2956244T3 (pl)
FI (1) FI3660073T3 (pl)
HK (1) HK1138303A1 (pl)
HR (3) HRP20231117T3 (pl)
HU (3) HUE063170T2 (pl)
LT (2) LT3202814T (pl)
PL (3) PL3660073T3 (pl)
PT (3) PT3660073T (pl)
SI (3) SI3202814T1 (pl)
WO (1) WO2008100532A1 (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8313763B2 (en) 2004-10-04 2012-11-20 Tolmar Therapeutics, Inc. Sustained delivery formulations of rapamycin compounds
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
MX2008009125A (es) 2006-01-18 2008-10-23 Qps Llc Composiciones farmaceuticas con estabilidad mejorada.
FI3660073T3 (fi) 2007-02-15 2023-09-11 Tolmar International Ltd Matalan purskeen poly(laktidi-ko-glykolidi)
CN101801415B (zh) * 2007-05-25 2015-09-23 Rb医药品有限公司 利培酮化合物的持续递送制剂
US8877225B2 (en) 2008-06-03 2014-11-04 Tolmar Therapeutics, Inc. Controlled release copolymer formulation with improved release kinetics
US10350159B2 (en) 2010-05-31 2019-07-16 Laboratories Farmacéuticos Rovi, S.A. Paliperidone implant formulation
US10335366B2 (en) 2010-05-31 2019-07-02 Laboratorios Farmacéuticos Rovi, S.A. Risperidone or paliperidone implant formulation
EP2394663B1 (en) 2010-05-31 2021-10-13 Laboratorios Farmaceuticos Rovi, S.A. Compositions for injectable in-situ biodegradable implants
US10285936B2 (en) 2010-05-31 2019-05-14 Laboratorios Farmacéuticos Rovi, S.A. Injectable composition with aromatase inhibitor
US10881605B2 (en) 2010-05-31 2021-01-05 Laboratorios Farmaceuticos Rovi, S.A. Methods for the preparation of injectable depot compositions
US10463607B2 (en) 2010-05-31 2019-11-05 Laboratorios Farmaceutics Rofi S.A. Antipsychotic Injectable Depot Composition
SI2394664T1 (sl) 2010-05-31 2016-10-28 Laboratorios Farmaceuticos Rovi, S.A. Antipsihotični depojski sestavek za injiciranje
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
GB2481018B (en) 2010-06-08 2015-03-18 Rb Pharmaceuticals Ltd Injectable flowable composition comprising buprenorphine
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
CN103421172B (zh) * 2012-05-23 2016-01-20 上海现代药物制剂工程研究中心有限公司 一种生物可降解聚酯的纯化工艺
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
CN105163719B (zh) 2013-03-11 2019-03-08 度瑞公司 包含高粘度液体载体的可注射控制释放组合物
US10011681B2 (en) 2013-04-11 2018-07-03 Mitsui Chemicals, Inc. Process for producing a lactic acid-glycolic acid copolymer or a salt thereof
KR20160100992A (ko) * 2013-12-06 2016-08-24 엔비시아 테라퓨틱스 인코포레이티드 눈의 병태의 치료를 위한 전방내 이식물
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US20160106804A1 (en) * 2014-10-15 2016-04-21 Yuhua Li Pharmaceutical composition with improved stability
CA3015557C (en) 2014-11-07 2019-07-16 Indivior Uk Limited The use of sustained-release buprenorphine formulations for the treatment of pain or opioid use disorders
WO2017062770A1 (en) 2015-10-08 2017-04-13 Silverberg Noah Punctal plug and bioadhesives
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
CN108498456B (zh) * 2018-05-16 2021-01-01 丽珠医药集团股份有限公司 一种阿立哌唑缓释微球及其制备方法
JP7451732B2 (ja) 2020-02-06 2024-03-18 オキュラ セラピューティクス，インコーポレイテッド 眼疾患を治療するための組成物及び方法
BR112023005807A2 (pt) 2020-09-30 2023-05-02 Tolmar International Ltd Sistema de liberação de polímero biodegradável para liberação prolongada de testosterona

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2551756B2 (ja) 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
DE3641692A1 (de) 1986-12-06 1988-06-09 Boehringer Ingelheim Kg Katalysatorfreie resorbierbare homopolymere und copolymere
DE3708916A1 (de) 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
US5702716A (en) 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
ATE168391T1 (de) 1990-04-13 1998-08-15 Takeda Chemical Industries Ltd Biologisch abbaubare hochmolekulare polymere, ihre herstellung und ihre verwendung
USRE37950E1 (en) 1990-04-24 2002-12-31 Atrix Laboratories Biogradable in-situ forming implants and methods of producing the same
US6353030B1 (en) * 1990-08-01 2002-03-05 Novartis Ag Relating to organic compounds
AU2605592A (en) 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
EP0560014A1 (en) 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US5681873A (en) 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
DE69524398T2 (de) 1994-04-08 2002-07-18 Atrix Lab Inc Flüssige mittel zur wirkstoffabgabe
DK0814778T3 (da) 1995-03-10 2001-09-17 Roche Diagnostics Gmbh Polypeptidholdige farmaceutiske administrationsformer i form af mikropartikler og fremgangsmåde til fremstilling deraf
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
JP4317599B2 (ja) 1996-06-26 2009-08-19 武田薬品工業株式会社 徐放性製剤
US6264970B1 (en) 1996-06-26 2001-07-24 Takeda Chemical Industries, Ltd. Sustained-release preparation
CN1195788C (zh) 1997-10-03 2005-04-06 麦克罗梅德公司 具有可逆热胶凝性质的可生物降解低分子量三嵌段聚(丙交酯－共聚－乙交酯)聚乙二醇共聚物
US6261583B1 (en) 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6565874B1 (en) 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US6143314A (en) 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6355657B1 (en) 1998-12-30 2002-03-12 Atrix Laboratories, Inc. System for percutaneous delivery of opioid analgesics
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
JP5046447B2 (ja) 2000-08-07 2012-10-10 和光純薬工業株式会社 乳酸重合体及びその製造方法
TWI225416B (en) 2001-06-29 2004-12-21 Takeda Chemical Industries Ltd Sustained-release composition and process for producing the same
JP5188670B2 (ja) * 2001-06-29 2013-04-24 武田薬品工業株式会社 徐放性組成物およびその製造法
US20060034889A1 (en) * 2004-08-16 2006-02-16 Macromed, Inc. Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
KR20070083941A (ko) * 2004-10-04 2007-08-24 큐엘티 유에스에이, 인코포레이티드 중합체 전달 조성을 갖는 눈 전달
RS53890B1 (en) 2004-11-10 2015-08-31 Tolmar Therapeutics, Inc. STABILIZED POLYMER DELIVERY SYSTEM
JP5647788B2 (ja) * 2006-10-11 2015-01-07 トルマー セラピューティクス， インコーポレイテッド． 超臨界流体抽出による低バースト特性の生分解性ポリエステルの調製
FI3660073T3 (fi) 2007-02-15 2023-09-11 Tolmar International Ltd Matalan purskeen poly(laktidi-ko-glykolidi)

Also Published As

Publication number Publication date
EP2115029A1 (en) 2009-11-11
JP5342459B2 (ja) 2013-11-13
EP3660073B1 (en) 2023-07-12
JP2010519218A (ja) 2010-06-03
LT3660073T (lt) 2023-10-10
SI3660073T1 (sl) 2023-10-30
WO2008100532A1 (en) 2008-08-21
PL2115029T3 (pl) 2016-01-29
ES2755374T3 (es) 2020-04-22
SI3202814T1 (sl) 2019-12-31
DK2115029T3 (en) 2015-10-05
DK3202814T3 (da) 2019-11-25
US20170216395A1 (en) 2017-08-03
JP6195587B2 (ja) 2017-09-13
SI2115029T1 (sl) 2016-01-29
FI3660073T3 (fi) 2023-09-11
LT3202814T (lt) 2019-12-10
PT3660073T (pt) 2023-08-31
US9561282B2 (en) 2017-02-07
HUE025842T2 (en) 2016-04-28
CY1122304T1 (el) 2021-01-27
US10206970B2 (en) 2019-02-19
ES2956244T3 (es) 2023-12-15
EP3202814B1 (en) 2019-10-16
JP2013224339A (ja) 2013-10-31
US20220202941A1 (en) 2022-06-30
HK1138303A1 (en) 2010-08-20
HUE047775T2 (hu) 2020-05-28
HUE063170T2 (hu) 2024-01-28
US20170095560A1 (en) 2017-04-06
PL3660073T3 (pl) 2023-12-27
CA2678350A1 (en) 2008-08-21
US11717572B2 (en) 2023-08-08
US11147880B2 (en) 2021-10-19
US20190209643A1 (en) 2019-07-11
JP5848290B2 (ja) 2016-01-27
ES2550014T3 (es) 2015-11-03
EP2115029B1 (en) 2015-09-16
US9655970B2 (en) 2017-05-23
US9974824B2 (en) 2018-05-22
DK3660073T3 (da) 2023-09-18
CA2678350C (en) 2015-11-17
HRP20150997T1 (hr) 2015-12-18
EP3660073A1 (en) 2020-06-03
US20160106847A1 (en) 2016-04-21
US20180311305A1 (en) 2018-11-01
PT3202814T (pt) 2019-11-26
US20100292195A1 (en) 2010-11-18
HRP20192055T1 (hr) 2020-02-21
JP2015127351A (ja) 2015-07-09
HRP20231117T3 (hr) 2023-12-22
EP3202814A1 (en) 2017-08-09
CY1116785T1 (el) 2017-03-15
US9187593B2 (en) 2015-11-17
PT2115029E (pt) 2015-10-26

Similar Documents

Publication Publication Date Title
SI2115029T1 (sl) Poli-(laktid/glikolid) z zmanjšanim takojšnjim učinkom sproščanja in metode za izdelavo polimerov
EP2274043A4 (en) BIODEGRADABLE METAL-CHELATING POLYMERS AND VACCINES
EP2424442A4 (en) MENUSKUSREPARATURSYSTEME AND PROCEDURE
EP2348063A4 (en) BIODEGRADABLE POLYESTERS AND PREPARATION METHOD THEREOF
EP2411440A4 (en) IMPROVED BIODEGRADABLE POLYMERS
PL2276789T3 (pl) Alifatyczno-aromatyczny biodegradowalny poliester
IL209188A (en) Sweetener, preparations containing it and methods of manufacture
EP2391714A4 (en) LIGATURE METHODS AND USES THEREOF
PL3284767T3 (pl) Biodegradowalna kompozycja zawierająca polimery pochodzenia naturalnego i kopoliestry alifatyczno-aromatyczne
EP2300645A4 (en) BIODEGRADABLE POLYESTERCOPOLYMERS
EP2404443A4 (en) TARGETED DISSEMINATION FROM PUBLIC DISPLAYS AND ASSOCIATED ARRANGEMENTS
GB0902052D0 (en) Polymers,composition and use
EP2323671A4 (en) BIODEGRADABLE AABB POLY (DEPSIPEPTIDE) POLYMERS AND METHOD FOR THEIR USE
EP2367866A4 (en) POLYESTER, MANUFACTURING METHOD THEREFOR AND USE
GB0802550D0 (en) Polymers and articles thereof
EP2496629A4 (en) UV LIGHT ABSORBENT COMPLEX POLYESTER POLYMERS, COMPOSITIONS WITH UV LIGHT ABSORBENT COMPLEX POLYESTER POLYMERS AND METHOD THEREFOR
EP2349077A4 (en) BIORESORBABLE POLYMERIC COMPOSITIONS AND MEDICAL DEVICES
EP2296629A4 (en) BIO-COMPATIBLE AND BIODEGRADABLE ELASTOMER POLYMERS
EP2414456A4 (en) DEGRADABLE POLYMER COMPOSITIONS AND USES THEREOF
EP2581371A4 (en) PYRROLYL-SUBSTITUTED DIHYDROINDOL-2-ON DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USES THEREOF
GB2465510B (en) Signal generator and method
SI2244739T1 (sl) Vodotopni polimeri, ki vsebujejo selen, in njihovi konjugati
EP2480588A4 (en) RECONSTITUTABLE INVERTED HEAT GELING POLYMERS
EP2395009A4 (en) POLYLACTIDE RESIN AND METHOD OF MANUFACTURING THEREOF
GB2469497B (en) Polymers comprising fluorene derivative repeat units and their preparation